Live Breaking News & Updates on Salarius pharmaceuticals

Stay informed with the latest breaking news from Salarius pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Salarius pharmaceuticals and stay connected to the pulse of your community

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Short Interest Update

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Short Interest Update
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Millennium-management , Armistice-capital , Salarius-pharmaceuticals-company-profile , News-ratings-for-salarius-pharmaceuticals-daily , Salarius-pharmaceuticals-inc , Salarius-pharmaceuticals-price-performance , Salarius-pharmaceuticals , Renaissance-technologies , Institutional-investors-weigh-in-on-salarius-pharmaceuticals , Get-free-report

SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023

Salarius Pharmaceuticals (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from…

Salarius-pharmaceuticals , Place-earnings , News , Ggregator , Reaking-news , Uration , Edia ,

Salarius Pharmaceuticals Reports Fourth Quarter and Full

Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic...

Houston , Texas , United-states , Kim-sutton-golodetz , William-mcvicar , Md-anderson-cancer-center , Drug-administration , Salarius-pharmaceuticals-board-of-directors , Linkedin , Product-development-award , Research-institute-of-texas , Company-ewing

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

22.03.2024 - Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant Expense-reduction Measures to Extend Cash Runway ...

Houston , Texas , United-states , William-mcvicar , Kim-sutton-golodetz , Research-institute-of-texas , Md-anderson-cancer-center , Company-ewing , Salarius-pharmaceuticals-board-of-directors , Linkedin , Salarius-pharmaceuticals-inc-nasdaq , Exchange-commission

Salarius: Q4 Earnings Snapshot

Salarius: Q4 Earnings Snapshot
qz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qz.com Daily Mail and Mail on Sunday newspapers.

Houston , Texas , United-states , Zacks-investment-research , Salarius-pharmaceuticals-inc , Salarius-pharmaceuticals , Automated-insights , Zacks-investment ,

Salarius Pharmaceuticals (SLRX) Issues Update on Strategic Review Process, Will Support Ongoing Seclidemstat Clinical Trials by Further Cost Cuts

Salarius Pharmaceuticals (SLRX) Issues Update on Strategic Review Process, Will Support Ongoing Seclidemstat Clinical Trials by Further Cost Cuts
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

William-mcvicar , David-arthur , Salarius-pharmaceuticals-inc , Nasdaq , Canaccord-genuity , Md-anderson-cancer-center , Salarius-pharmaceuticals , Cancer-center , Salariu-phase , Chief-executive-officer ,